In our analysis, patients with increased DYRK1B expression levels showed several significant features of heart failure with reduced ejection fraction (HFrEF), while there were no differences in age, gender distribution, BMI, diabetes mellitus, atrial fibrillation, renal function, coronary artery status, or patient treatment (Table 1). The gene discussed is DYRK1B; the disease is atrial fibrillation.